WEST PALM BEACH, Fla. (February 13, 2023) — InnovaQor, Inc. (OTC: VMCS), confirms a
new trading symbol, INQR, for its common shares will be effective on February 14, 2023
InnovaQor is pleased to confirm that FINRA has today confirmed the name change from
VisualMED Clinical Solutions Corporation to InnovaQor, Inc., and the change of its trading
symbol for its common stock from VMCS to INQR on OTC Markets, will be effective on
February 14, 2023. The Companys’ common shares will trade under the symbol INQR on OTC
Markets at the open of markets on February 14, 2023. There is no change to the cusip number
representing the Companys’ common shares.
“We are pleased to have these final transition changes completed” said Sharon Hollis, CEO of
InnovaQor, Inc. “We can now focus on creating a strong brand and trading history, for our
new business and strategy”
For further information on InnovaQor, Inc., please visit www.innovaqor.com
About InnovaQor, Inc.
InnovaQor delivers innovative technology and software solutions for the medical sector and
intends to build a communication platform specifically for the medical sector, which will
facilitate communication and collaboration between peers and allow the addition of revenue
generating bolt on offers, including existing solutions and a new recruitment matching
product for the healthcare sector.
Forward-Looking Statements
This press release includes “forward-looking statements” within the meaning of the safe
harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual
results may differ from expectations and, consequently, you should not rely on these forward-
looking statements as predictions of future events. Words such as “expect,” “estimate,”
“project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,”
“should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended
to identify such forward-looking statements. These forward-looking statements involve
significant risks and uncertainties that could cause the actual results to differ materially from
the expected results. Additional information concerning these, and other
risk factors, is contained in the Company’s most recent filings with the Securities and
Exchange Commission. The Company cautions readers not to place undue reliance upon any
forward-looking statements, which speak only as of the date made. The Company does not
undertake or accept any obligation or undertaking to release publicly any updates or revisions
to any forward-looking statements to reflect any change in their expectations or any change
in events, conditions, or circumstances on which any such statement is based, except as
required by law.
Contact:
Gerard Dab
561 421 1905
press@innovaqor.com
